Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Stuart J Connolly

Efficacy and Safety of Dabigatran Versus Warfarin From the RE-LY Trial

Open Heart
Cardiovascular MedicineCardiology
2018English

Related publications

Response to Letters Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Letter by Chin Et Al Regarding Article, "Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Letter by Hjemdahl Et Al Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Regional Differences in Patient Characteristics and Outcomes During Uninterrupted Anticoagulation With Dabigatran Versus Warfarin in Catheter Ablation of Atrial Fibrillation: The RE-CIRCUIT Study

Journal of Interventional Cardiac Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2019English

Pcv51 - Cost Analysis of Safety Outcomes of Dabigatran vs. Warfarin in the Spanish National Health Service

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Letter by Reynolds Et Al Regarding Article, "Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

The Efficacy and Safety of Apixaban Versus Warfarin Are Preserved in Patients With Atrial Fibrillation and Extreme Body Weight: Insights From the Aristotle Study

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Dabigatran Compared With Rivaroxaban vs Warfarin

JAMA Internal Medicine
Internal Medicine
2017English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy